These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22705189)

  • 1. Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.
    Mak LH; Knott J; Scott KA; Scott C; Whyte GF; Ye Y; Mann DJ; Ces O; Stivers J; Woscholski R
    Bioorg Med Chem; 2012 Jul; 20(14):4371-6. PubMed ID: 22705189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.
    Sodeoka M; Sampe R; Kojima S; Baba Y; Usui T; Ueda K; Osada H
    J Med Chem; 2001 Sep; 44(20):3216-22. PubMed ID: 11563920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25.
    Lazo JS; Aslan DC; Southwick EC; Cooley KA; Ducruet AP; Joo B; Vogt A; Wipf P
    J Med Chem; 2001 Nov; 44(24):4042-9. PubMed ID: 11708908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.
    Lazo JS; Nemoto K; Pestell KE; Cooley K; Southwick EC; Mitchell DA; Furey W; Gussio R; Zaharevitz DW; Joo B; Wipf P
    Mol Pharmacol; 2002 Apr; 61(4):720-8. PubMed ID: 11901209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries.
    Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P
    Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cinnamic acid derivative that inhibits Cdc25 dual-specificity phosphatase activity.
    Aoyagi Y; Masuko N; Ohkubo S; Kitade M; Nagai K; Okazaki S; Wierzba K; Terada T; Sugimoto Y; Yamada Y
    Cancer Sci; 2005 Sep; 96(9):614-9. PubMed ID: 16128747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries.
    Jing L; Wu G; Hao X; Olotu FA; Kang D; Chen CH; Lee KH; Soliman MES; Liu X; Song Y; Zhan P
    Eur J Med Chem; 2019 Dec; 183():111696. PubMed ID: 31541869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
    Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
    J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
    Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS
    Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
    Schepetkin IA; Karpenko AS; Khlebnikov AI; Shibinska MO; Levandovskiy IA; Kirpotina LN; Danilenko NV; Quinn MT
    Eur J Med Chem; 2019 Dec; 183():111719. PubMed ID: 31563013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase.
    Brisson M; Nguyen T; Vogt A; Yalowich J; Giorgianni A; Tobi D; Bahar I; Stephenson CR; Wipf P; Lazo JS
    Mol Pharmacol; 2004 Oct; 66(4):824-33. PubMed ID: 15231869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
    Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and inhibition of Cdc25 phosphatases by vitamin K analogues.
    Kar S; Lefterov IM; Wang M; Lazo JS; Scott CN; Wilcox CS; Carr BI
    Biochemistry; 2003 Sep; 42(35):10490-7. PubMed ID: 12950176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases.
    Valente S; Bana E; Viry E; Bagrel D; Kirsch G
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5827-30. PubMed ID: 20800482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
    Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and functional evaluation of triazine-based bivalent agents that simultaneously target the active site and hot spot of phosphatase Cdc25B.
    Nagaoka Y; Parvatkar P; Hirai G; Ohkanda J
    Bioorg Med Chem Lett; 2021 Sep; 48():128265. PubMed ID: 34273487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and biological activities of a novel group of steroidal derived inhibitors for human Cdc25A protein phosphatase.
    Peng H; Xie W; Otterness DM; Cogswell JP; McConnell RT; Carter HL; Powis G; Abraham RT; Zalkow LH
    J Med Chem; 2001 Mar; 44(5):834-48. PubMed ID: 11262093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of the naphthalene-derived inhibitors against Cdc25A dual-specificity protein phosphatase and their biological activity.
    Shimbashi A; Tsuchiya A; Imoto M; Nishiyama S
    Bioorg Med Chem Lett; 2005 Jan; 15(1):61-5. PubMed ID: 15582411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdc25B phosphatase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective.
    Lavecchia A; Coluccia A; Di Giovanni C; Novellino E
    Anticancer Agents Med Chem; 2008 Dec; 8(8):843-56. PubMed ID: 19075567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EK-6136 (3-methyl-4-(O-methyl-oximino)-1-phenylpyrazolin-5-one): a novel Cdc25B inhibitor with antiproliferative activity.
    Kim KR; Kwon JL; Kim JS; No Z; Kim HR; Cheon HG
    Eur J Pharmacol; 2005 Dec; 528(1-3):37-42. PubMed ID: 16324698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.